entity

D+Q

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about D+Q: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
0Hypotheses
1Analyses
1Outgoing
0Incoming
0Experiments
1Debates

No AI portrait yet

Wiki Pages (2)

Knowledge base pages for this entity

Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's Disease

experiment · 1389 words

Dasatinib + Quercetin (D+Q) for Neurodegeneration

therapeutic · 1137 words

Outgoing (1)

TargetRelationTypeStr
Senescent Cellsinhibitscell_type0.70

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

What distinguishes truly senescent brain cells from merely dysfunctional reactiv

cellular senescence | 2026-04-11 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

Multiple participants noted the conflation of cellular dysfunction with senescen

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

Related Research

Hypotheses and analyses mentioning D+Q in their description or question text

No additional research found